METHODS TO PREDICT RESPONSE TO IMMUNOTHERAPY IN METASTATIC MELANOMA

The present invention relates to methods for determining or predicting if a patient having a predetermined disease, for example cancer, in particular metastatic melanoma, is responsive, or will respond to a treatment based on immune checkpoint inhibitor. The present invention also relates to compute...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MONNIER-BENOIT, Sylvain, CIARLONI, Laura, DURANDAU, Eric, WOSIKA, Victoria, HADADI, Noushin, HOSSEINIAN EHRENSBERGER, Sahar
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to methods for determining or predicting if a patient having a predetermined disease, for example cancer, in particular metastatic melanoma, is responsive, or will respond to a treatment based on immune checkpoint inhibitor. The present invention also relates to computer-implemented methods for implementing said methods and to kits. La présente invention concerne des méthodes visant à déterminer ou à prédire si un patient atteint d'une maladie prédéterminée, par exemple un cancer, en particulier un mélanome métastatique, est sensible ou répondra à un traitement basé sur un inhibiteur de point de contrôle immunitaire. La présente invention concerne également des méthodes mises en œuvre par ordinateur pour mettre en œuvre lesdites méthodes et des kits.